These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28248039)

  • 1. [Association of lower urinary tract symptoms and testosterone deficiency in men with type 2 diabetes].
    Kogan MI; Belousov II; Ibishev HS; Cherniy AA; Khripun IA; Vorobyev SV; Sizjakin DV
    Urologiia; 2016 Dec; (6):22-26. PubMed ID: 28248039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Otunctemur A; Ozbek E; Besiroglu H; Dursun M; Sahin S; Koklu I; Erkoc M; Danis E; Bozkurt M; Gurbuz A
    Int J Urol; 2014 Dec; 21(12):1268-72. PubMed ID: 25056570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
    Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
    J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes.
    Caretta N; Vigili de Kreutzenberg S; Valente U; Guarneri G; Pizzol D; Ferlin A; Avogaro A; Foresta C
    Andrology; 2015 Nov; 3(6):1062-7. PubMed ID: 26339755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients.
    Ozcan L; Besiroglu H; Dursun M; Polat EC; Otunctemur A; Ozbek E
    Arch Ital Urol Androl; 2017 Mar; 89(1):26-30. PubMed ID: 28403591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Testosterone Level on Lower Urinary Tract Symptoms.
    Crawford ED; Poage W; Nyhuis A; Price DA; Dowsett SA; Muram D
    Am J Mens Health; 2016 Sep; 10(5):440-2. PubMed ID: 26077271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
    Park SG; Yeo JK; Cho DY; Park MG
    Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome associated with reduced lower urinary tract symptoms in middle-aged men receiving health checkup.
    Yang TK; Hsieh JT; Chen SC; Chang HC; Yang HJ; Huang KH
    Urology; 2012 Nov; 80(5):1093-7. PubMed ID: 23107400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia.
    Kang M; Kim M; Choo MS; Bae J; Ku JH; Yoo C; Oh SJ
    Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
    Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
    Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
    Martov AG; Ergakov DV
    Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
    Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and benign prostatic hyperplasia.
    Jarvis TR; Chughtai B; Kaplan SA
    Asian J Androl; 2015; 17(2):212-6. PubMed ID: 25337845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?
    Sarma AV; Parsons JK; McVary K; Wei JT
    J Urol; 2009 Dec; 182(6 Suppl):S32-7. PubMed ID: 19846144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.
    Marberger M; Roehrborn CG; Marks LS; Wilson T; Rittmaster RS
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1323-8. PubMed ID: 16434455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.